Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Return on Invested Capital (2016 - 2025)

Mimedx's Return on Invested Capital history spans 12 years, with the latest figure at 0.18% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 4.0% year-over-year to 0.18%; the TTM value through Dec 2025 reached 0.18%, down 4.0%, while the annual FY2025 figure was 0.19%, 5.0% down from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.18% at Mimedx, up from 0.17% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 1.01% in Q4 2023 and bottomed at 1.92% in Q1 2021.
  • The 5-year median for Return on Invested Capital is 0.16% (2025), against an average of 0.09%.
  • The largest annual shift saw Return on Invested Capital plummeted -182bps in 2021 before it soared 170bps in 2022.
  • A 5-year view of Return on Invested Capital shows it stood at 0.16% in 2021, then crashed by -221bps to 0.5% in 2022, then skyrocketed by 301bps to 1.01% in 2023, then crashed by -78bps to 0.22% in 2024, then decreased by -16bps to 0.18% in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Return on Invested Capital are 0.18% (Q4 2025), 0.17% (Q3 2025), and 0.15% (Q2 2025).